arrow
J

Julia A. Tree

durham university
H指数:30
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ultrafine particulate matter emitted from ships drives inflammation and susceptibility to viral infection

船舶排放的超细颗粒物驱动炎症并增加病毒感染易感性

2026-07-010
OAAI
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance
2023-11-232
OAAI
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments (vol 13, 13912, 2023)
2023-09-180
OAAI
Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments
2023-08-251
OAAI
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
2023-03-1313
OAAI
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers

使用LeTRS分析细胞培养,动物模型和临床样品中SARS-CoV-2已知和新的亚基因组mrna,这是一种用于识别独特序列标识符的生物信息学工具

2022-05-2611
OAAI
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction
2022-03-2965
OAAI
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

抗RBD人单克隆抗体的结构和治疗SARS-CoV-2的潜力

2022-01-018
OAAI
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
2021-09-2294
OAAI
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
2021-02-24115
OAAI
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (vol 27, pg 846, 2020)
2021-02-033
OAAI
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
2021-01-22222
OAAI
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
2021-01-04129
OAAI
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations

普通肝素在治疗相关浓度下抑制活野生型SARS-CoV-2细胞感染性

2020-12-1472
OAAI
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (vol 27, pg 846, 2020)
2020-10-152
OAAI
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
2020-08-21120
OAAI